Home » Tenders » Americas » USA » Barda's Rrpv - Request for Information - Central Influenza Virus and Emerging... Tender

Barda's Rrpv - Request for Information - Central Influenza Virus and Emerging Infectious... Tender

Download Documents

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Barda's Rrpv - Request for Information - Central Influenza Virus and Emerging Infectious Disease Immunogenicity Laboratory ServiceS. The project location is USA and the tender is closing on 19 Apr 2024. The tender notice number is RFI-24-07-IEID, while the TOT Ref Number is 99568109. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Barda's Rrpv - Request for Information - Central Influenza Virus and Emerging Infectious Disease Immunogenicity Laboratory ServiceS

Deadline : 19 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 99568109

Document Ref. No. : RFI-24-07-IEID

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : Washington, DC 20201
Primary Point of Contact : Wendy Rehman
wendy.rehman@ati.org

USA
Email :wendy.rehman@ati.org

Tender Details

Description

The purpose of this posting is to provide notice of a Request for Information (RFI) and to make interested parties aware of an upcoming Industry Day on April 16th, 2024 to inform a potential new Request for Project Proposal (RPP) under the Biomedical Advanced Research and Development Authority's (BARDA) Rapid Response Partnership Vehicle (RRPV) for the Central Influenza Virus and Emerging Infectious Disease Immunogenicity Laboratory Services. BARDA is interested in learning more about the requested laboratory services that will support advanced research and development of influenza virus vaccines and emerging infectious diseases vaccines, including support for Phase 1, 2, and 3 clinical trial endpoints.

To view the full RFI, including the specific questions for which BARDA is seeking answers, as well as to access further information about attending the upcoming Industry Day, please view the "RFI - Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services" posting via the RRPV website at https://www.rrpv.org/solicitation/request-for-information/rfi-central_flu_lab/.
Active Contract Opportunity Notice ID RFI-24-07-IEID Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Office ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 01, 2024 03:28 pm EDT
Original Response Date: Apr 19, 2024 04:30 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 04, 2024
Initiative:
Classification
Original Set Aside:
Product Service Code: AN42 - Health R&D Services; Health Care - Other; Applied Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance: USA